GSK, Janssen, and Meiji Seika Pharma were all featured in the NTM therapeutics market report on July 17, 2025.
1 report, 1 independent
Updated Jul 17
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
GSK, Janssen, and Meiji Seika Pharma were all featured in the NTM therapeutics market report on July 17, 2025.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
GSK
British multinational pharmaceutical and biotechnology company
Nothing else this week.
-
Janssen
company in Cologno Monzese, Italy
Nothing else this week.
-
Meiji Seika Pharma
Japanese food and pharmaceutical company
Nothing else this week.
Coverage
Newest first; wire copies grouped- GlobeNewswireNontuberculous Mycobacteria (NTM) Opportunity Assessment and Forecast to 2033 Featuring Janssen, Novartis, Meiji Seika Pharma, Insmed, Daiichi Sankyo, MannKind, Paratek, Nobelpharma, GSK, Pfizer Comp